NCT03109080: Olaparib & Radiation Therapy for Patients Triple Negative Breast Cancer (TNBC)

Breast Cancer Type: Triple Negative
Hormone Mutations:
Other Mutations: 
Breast Cancer Tissue: Inflammatory breast cancer (IBC)
Recruitment Status: Active, not recruiting
Phase 1
Drug Category: Misc Inhibitor, Radiation Therapy

Key Eligibility Criteria:

Gender: Female
Age: 18 Years and older (Adult, Senior)
Location of Metastases: 
Additional Notes: Must be affiliated with the French Social Security System

Comments are closed.

Up ↑